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1. Int~du~tion 
In this laboratory we are concerned with elucida- 
tion of the mechanisms regulating mitochondrial 
biogenesis. It has been hypothesized [ 1,2] that mito- 
chondrial assembly is controlled by lytic enzymes 
through selective limination of components that fail 
to perform properly. Our recent report [3] has 
provided evidence that mitochondrial formation 
during yeast growth in a galactose medium is indeed 
accompanied by appearance of respiratory chain 
components which prove to be inactive (most probably 
due to improper alignment within the membrane) 
and are proteolytically eliminated. It, however, 
remained uncertain whether such phenomena re 
general or only a unique property of the particular 
experimental conditions. 
The present work demonstrates that such non- 
functioning components of the mitochondrial 
respiratory chain are also retained uring yeast growth 
in a glucose medium in the presence of proteinase 
inhibitors. 
2. Materials and methods 
Saccharomyces cerevisiae were grown batchwise 
as described [4] in a medium containing 2.5 g glucose, 
1 g KH2P04, 1 g (NH4)aS04, 0.5 g MgSO,, and 2 g 
yeast extract (Serva, Heidelberg) per litre. Phenyl- 
methyl sulfonyl fluoride (PMSF) was added to the 
cell suspension i portions of 50 pmol/l at intervals 
of 90-120 min, beginning from 6-7 h of growth, to 
a cumulative 2.5 X 10m4 M. Pepstatin was added twice, 
E~sev~erfNortb-Holland Biomedical Press 
at 6 and 9 h of growth, at 0.5 mg/l suspension 
(cumulative 1.5 X 10e6 M). 
Membrane fractions containing the entire 
mitochondrial populations were isolated as in [3] 
from early stationary (I 6 h of growth) control and 
PMSF-grown cells. 
3. Results and discussion 
The development of yeast respiratory system was 
initially studied by measuring the changes in cell 
respiration and in the overall content of mitochondrial 
cytochromes in intact cells during growth in culture 
with and without proteinase inhibitors, PMSF and 
pepstatin. 
The growth rate was only slightly and transiently 
inhibited by PMSF or pepstatin, and the culture 
completely recovered within 2 h from the first addi- 
tion. By the early stationa~ phase identical cell 
numbers (“6 X 10’ cells/ml) and biomass yields 
(0.88 g dry wt cells/l suspension) were obtained with 
control, PMSF- and pepstatin-grown batches. These 
results are in complete accord with our earlier observa- 
tions [5] which have been confirmed [6]. 
Cell respiration, which is evidently respiratory 
chain-determined since it is completely inhibited by 
1 mM KCN or 2 X lo-’ M antimycin and con- 
siderably stimulated by CCCP, is not affected by 
proteinase inhibitors. At the same time, during yeast 
growth in the presence of antiproteolytic agents 
cytochromes c, cl, b and @a3 gradually accumulate 
above the corresponding control levels, so that by the 
early stationary phase the cytochrome content in 
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Characteristics of mitochondrial populations from control and PMSF-grown yeast cells 
Source of 
preparation 
Control 
PMSF-grown 
Cytochrome contents (nmol/g dry wt. cells) 
cyt. c + f, cyt. b cyt. f&r3 
41.7 57.8 14.4 
52.0 72.0 18.5 
Succinate oxidase (@g-atoms 
O/min .g dry wt cells) 
+ 5 &I cyt. c 
46.0 61.2 
46.5 60.4 
Ascorbate oxidase, Ubiquinol oxidase Succinate : cyt. c reductase 
(@g-atoms O/min .g (rrmol CoQ, oxidized/ (pm01 cyt. c reduced/min _g 
dry wt cells) mm .g dry wt cells) dry wt cells) 
Control 
PMSF-grow 
112 
115 
44.0 
45.0 
81.0 
79.5 
Mitochondrial populations were obtained from stationary cells as 70 000 X g membrane fractions [31. 
Cytochrome contents were calculated from the difference (reduced minus oxidized) room-temperature 
spectra using the following wavelength pairs and extinction coefficients: cyt. c + c, (551-540 mn) 
20 mM_’ .cm-*, (cyt. b (562-575 nm) 19.1 mM-r cm-‘, cyt. aa, (605-630 nm) 24 mM-’ .IXII-~ [7]. 
Activities were measured in 50 mM potassium phosphate (pH 7.4), 1 mM EDTA. Values presented are the 
maximal ones which were attained at the following substrate concentrations: succinate oxidase, 20 mM 
succinate; ascorbate oxidase, 20 mM ascorbate; TMPD, 1 mM; ubiquinol oxidase, 11 bM coenzyme Q, 
reduced according to [S]; succinate : cytochrome c reductase, 20 mM succinate, 15 @M cytochrome c 
PMSF-grown cells exceeds the control by 25%30%; 
the effect of pepstatin is only slightly less. 
Thus, growth in a glucose medium in the presence 
of proteinase inhibitors induces a discrepancy between 
cell respiration and cytochrome content similar to 
that observed with galactose-grown yeast [S]. 
This is confirmed by the characteristics of mito- 
chondrial populations isolated from the stationary 
control and PMSF-grown cells (table 1). As can be 
seen, preparations from inhibitor-treated cells contain 
25-30% more cytochromes c + cl, b and aa3 than 
the control ones, in accord with whole-cell deter- 
minations; succinate-reducible flavoproteins were also 
found to be 20-30% higher in mitochondrial popula- 
tions from PMSF-grown cells. Nevertheless, succinate 
oxidase and partial activities of the succinate oxidase 
chain prove to be identical in control and inhibitor- 
grown preparations, regardless of the concentration 
of substrates. 
In order to evaluate the potential catalytic capacity 
of the individual respiratory chain complexes (i.e., 
succinate : ubiquinone reductase, ubiquinol : 
cytochrome c reductase and cytochrome c oxidase), 
these enzymes were activated maximally by freezing- 
thawing the membrane preparations in the presence 
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of Lubrol WX (31. As exemplified in table 2, under 
such conditions all the above activities in preparations 
from PMSF-grown cells exceed the control ones. 
Moreover, the activities are nearly proportional to the 
spectrally determined contents of electron carriers 
comprising the corresponding complexes and display 
similar app. Km values (e.g., 3 &M CoQa at 20 mM 
succinate for complex II, 4.7 PM ferrocytochrome c 
at 0.24 mM dissolved oxygen for complex IV). Thus 
it seems that the ‘excess’ components retained in 
the presence of proteinase inhibitors, although 
possessing normal catalytic properties, do not partic- 
ipate in electron flow mainly because their improper 
alignment within the membrane hinders interaction 
with adjacent carriers. All this appears to be in 
perfect analogy to the results obtained with galactose- 
grown yeast [3]. 
Reconciliation of the data on glucose- and 
galactose-grown cells gives rise to several issues. 
(1) The reported phenomena can hardly be ascribed 
to any side effects of proteinase inhibitors like 
suppression or distortion of the synthesis and/or 
assembly of mitochondrial constituents, in view 
of the essential normality of the ‘excess’ respira- 
tory chain complexes. Some questions remain 
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Table 2 
Activities of the individual complexes of the respiratory chain in solubilized membrane preparations 
Preparation Succinate: CoQ reductase 
@mol CoQ reduced/min) 
CoQH, : cyt. c reductase 
(pm01 cyt. c reduced/min) 
Cytochrome oxidase 
@mol cyt. c oxidized/min) 
Control 52.2 77.0 51.5 
PMSF-grown 63.4 98.3 65.1 
Activation was achieved by freezing-thawing of the membrane preparations from control and PMSF- 
grown cells in the isolation medium with 0.05% Lubrol WX; the detergent was also present in the assay 
medium (see table 1) in concentrations producing maximal activation. Activities presented in table 2 
pertain to the following conditions: succinate : ubiquinone reductase, 20 mM succinate, 6.7 PM 
coenzyme Q, , 0.01% Lubrol; ubiquinol : cytochrome c reductase, 15 MM reduced coenzyme Q, , 11 PM 
cytochrome c, 0.03% Lubrol; cytochrome oxidase, 7 PM ferrocytochrome c, -0.24 mM dissolved oxygen, 
0.06% Lubrol. Activities are given per g dry wt cells 
obscure such as whether a precursor-processing 
machinery is operative in yeast respiratory chain 
assembly and, if so, whether it is affected by 
these antiproteolytic compounds. However, 
features very similar to those of the mitochondria 
of inhibitor-treated cells are found in the prepa- 
rations from control galactose-grown yeast at 
the earlier stages of respiratory development [3], 
which strongly argues in favour of such aberra- 
tions in respiratory chain arrangement being 
indeed naturally occurring. 
As neither integral nor partial respiratory chain 
activities are affected by elimination, retention 
(in galactose cultures [3 J) or accumulation (in 
glucose cultures) of a portion of respiratory 
chain components, it is most reasonable to con- 
clude that it is the inactive entities that are 
preferentially eliminated in normal conditions 
and preserved by proteinase inhibitors. Other- 
wise it has to be presumed that the changes in 
the amount of respiratory chains are somehow 
exactly compensated by activation or deactiva- 
tion of the whole mitochondrial population, 
which is hardly likely. 
The body of data obtained testifies that the 
appearance and selective elimination of non- 
functioning components are not the unique 
property of yeast growth on galactose, making it 
plausible that the principle of performance 
control by lytic enzymes is widely if not uni- 
versally applicable to mitochondrial biogenesis. 
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